NL
DE
15 March 2018
Publication: link
Graphical abstract of the review.
Willeke Daamen
In a recent review in the Journal of Controlled Release (5y IF 8), René Raavé (photo), Toin van Kuppevelt & Willeke Daamen, theme Reconstructive and regenerative medicine, discussed an alternative targeting strategy aimed at delivery of anti-tumor drugs to the tumoral extracellular matrix instead of tumor cells.
Publication: link
Graphical abstract of the review.
Willeke Daamen
Related news items
A collagen plug with shape memory to seal iatrogenic fetal membrane defects after fetoscopic surgery
5 July 2022 Minimally invasive fetoscopic surgery is a rising medical technology to treat the unborn child, however there is an urgent need to reduce the risks introduced by the surgery. The Plugging the Gap project focusses on a new approach to this problem and the first results were recently published. read more
Willeke Daamen ratified as ETRS board member
3 November 2021 Willeke Daamen, theme Reconstructive and regenerative medicine appointed as board member of The European Tissue Repair Society (ETRS). read more
Grant for early detection of ovarian cancer
5 June 2020 The Department of Biochemistry (Toin van Kuppevelt/Willeke Daamen), together with the Department of Gynecology, has been awarded a grant of 144 kEuro for the development of an assay for the early detection of ovarian cancer. read more
3 million euro for Marie Curie ITN SkinTERM
5 June 2020 The European Union has provisionally awarded a grant of more than 3 million euro to the SkinTERM project “Skin Tissue Engineering and Regenerative Medicine: From skin repair to regeneration”. SkinTERM is coordinated with Willeke Daamen as coordinator and Toin van Kuppevelt as vice coordinator. read moreFET-OPEN grant for Toin van Kuppevelt and Willeke Daamen
6 March 2020 A grant of 592 kEuro has been awarded to Toin van Kuppevelt and Willeke Daamen, theme Reconstructive and regenerative medicine, for a Horizon 2020 FET-OPEN project entitled “Heparin and heparan sulphate: from sequence determination to therapeutic strategies for Parkinson’s disease”. read more
